Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Doximity, Inc. | 10%+ Owner | Class B Common Stock | 8.56 M | $228 M | $26.65 | Dec 2, 2021 | Direct |
PMV Pharmaceuticals, Inc. | 10%+ Owner | Common Stock | 4.47 M | $9.97 M | $2.23 | Jul 13, 2021 | Direct |
Doximity, Inc. | 10%+ Owner | Class A Common Stock | 81.7 K | $2.31 M | $28.27 | Dec 2, 2021 | By: Khaled A. Nasr |
Doximity, Inc. | 10%+ Owner | Class A Common Stock | 54.8 K | $1.55 M | $28.27 | Dec 2, 2021 | By: Keval Desai |
PMV Pharmaceuticals, Inc. | 10%+ Owner | Common Stock | 25.6 K | $57 K | $2.23 | Jul 13, 2021 | By Gilbert H. Kliman |
PMV Pharmaceuticals, Inc. | 10%+ Owner | Common Stock | 4.2 K | $9.37 K | $2.23 | Jul 13, 2021 | By: Khaled A. Nasr |
PMV Pharmaceuticals, Inc. | 10%+ Owner | Common Stock | 2.82 K | $6.28 K | $2.23 | Jul 13, 2021 | By: Keval Desai |
Doximity, Inc. | 10%+ Owner | Class A Common Stock | 0 | $28.27 | Dec 2, 2021 | By: InterWest Management Partners X, LLC | |
Doximity, Inc. | 10%+ Owner | Class A Common Stock | 0 | $28.27 | Dec 2, 2021 | Direct | |
Doximity, Inc. | 10%+ Owner | Series A Preferred Stock | 0 | Jun 28, 2021 | Direct | ||
Doximity, Inc. | 10%+ Owner | Series B Preferred Stock | 0 | Jun 28, 2021 | Direct | ||
Doximity, Inc. | 10%+ Owner | Series C Preferred Stock | 0 | Jun 28, 2021 | Direct | ||
PMV Pharmaceuticals, Inc. | 10%+ Owner | Common Stock | 0 | $2.23 | Jul 13, 2021 | By: InterWest Management Partners X, LLC |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
DOCS | Doximity, Inc. | Dec 2, 2021 | 7 | $0 | 4 | Dec 6, 2021 | 10%+ Owner |
DOCS | Doximity, Inc. | Nov 12, 2021 | 7 | $0 | 4 | Nov 15, 2021 | 10%+ Owner |
PMVP | PMV Pharmaceuticals, Inc. | Jul 13, 2021 | 6 | $0 | 4 | Jul 14, 2021 | 10%+ Owner |
DOCS | Doximity, Inc. | Jun 28, 2021 | 7 | -$105 M | 4 | Jun 28, 2021 | 10%+ Owner |
DOCS | Doximity, Inc. | Jun 23, 2021 | 0 | $0 | 3 | Jun 23, 2021 | 10%+ Owner |
PMVP | PMV Pharmaceuticals, Inc. | May 10, 2021 | 6 | $0 | 4 | May 12, 2021 | 10%+ Owner |